What Works for Parkinson’s Disease Psychosis?

This activity is designed for general, pediatric and geriatric psychiatrists, neurologists, nurse practitioners, physician assistants, nurses, psychologists, social workers, other mental health professionals and primary care clinicians interested in treating patients tardive dyskinesia or Parkinson’s Disease.

Supported by an educational grant from:

Neurocrine Continental, Inc., a wholly-owned subsidiary of Neurocrine Biosciences, Inc.

Activity Information


Original Release Date: October 31, 2018
Expiration Date: October 31, 2019
Estimated Time to Complete Activity: 1.0 hour



Program Overview

Parkinson’s disease psychosis (PDP) is a common neuropsychiatric manifestation of Parkinson’s disease (PD); up to 60% of patients with PD experience psychotic symptoms for at least one month at some point during the course of their illness. PDP is characterized by hallucinations and delusions, as well as illusions and a false sense of presence. The burden of PDP is substantial for both the patient and the caregiver. PDP is a common reason for hospital admission, nursing home placement, and increased mortality. Until recently treatments for PDP have been limited by poor efficacy, poor tolerability, or both. A new treatment is efficacious for the treatment of PDP.

Learning Objectives

As a result of participating in this activity, participants should be able to:

  • Identify the neuropsychiatric manifestations of Parkinson's Disease
  • Explain the pathophysiology of Parkinson’s Disease Psychosis
  • Describe current strategies for the management of Parkinson’s Disease Psychosis

Method of Participation

Participants should read the activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a webpage that will allow you to receive your certificate of credit via email or you may print it out at that time.

The online post-test and evaluation can be accessed at https://tinyurl.com/PDPresent17

Inquiries about CME accreditation may be directed to the University of Cincinnati at forneyba@uc.edu or 513-558-3197.

Joint provider statements


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education. The University of Cincinnati is accredited by the ACCME to provide continuing education for physicians.

Physician Credit Designation
The University of Cincinnati designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants Credit Designation
The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Disclosure Information

As part of their efforts to ensure balance, independence, objectivity, and scientific rigor, the joint providers of this CME/CE activity have required the faculty and all others involved in the development of the content to disclose any relationships they may have with commercial companies that have a product or service relevant to this activity.

Faculty Disclosures

In accordance with Accreditation Council for Continuing Medical Education (ACCME) Essential Areas and Policies, information about the relationships of presenters with commercial interests (if any) will be included in materials distributed at the conference.

Leslie Citrome, MD, MPH, has indicated he is a Consultant for Acadia, Alkermes, Allergan, Intra-Cellular Therapeutics, Janssen, Lundbeck, Merck, Neurocrine, Noven, Otsuka, Pfizer, Shire and Sunovion; is a Speaker for Acadia, Alkermes, Allergan, Janssen, Lundbeck, Merck, Neurocrine, Otsuka, Pfizer, Shire, Sunovion, Takeda, Teva and Vanda; has Stocks in Bristol-Myers Squibb, Eli Lilly, J & J, Merck and Pfizer purchased > 10 years ago; and is a Royalty Recipient of Springer Healthcare (book), UpToDate (reviewer), and Wiley (Editor-in-Chief, International Journal of Clinical Practice).

Planning Committee Members

Shirley Jones No Relevant Relationships
Ruth Kollmer No Relevant Relationships
Margaret McLaughlin, PhD No Relevant Relationships
Rick Ricer, MD No Relevant Relationships
Susan P. Tyler No Relevant Relationships

Resolution of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support of CME, University of Cincinnati will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Off-Label Disclosure

The faculty have been instructed to identify investigational drugs or devices or discussion of drugs or devices that is outside of labeling currently approved by the US Food and Drug Administration.

Contact Information for Technical Questions

Please technical questions or concerns to Global Academy for Medical Education at 973-290-8225 or email info@globalacademycme.com.

Copyright Statement

Copyright © 2018 by Global Academy for Medical Education, LLC, Frontline Medical Communications Inc., and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, University of Cincinnati, Postgraduate Institute for Medicine, and Frontline Medical Communications will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.